Home › Bipolar Disorder › Arkansas
Bipolar Disorder clinical trials in Arkansas
6 studies for Bipolar Disorder are looking for participants at sites in Arkansas.
Cities in Arkansas
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Pillar Clinical Research, LLC, Little Rock
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 25, 2026 · NCT06372964Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Pillar Clinical Research, LLC, Little Rock
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Woodland International Research Group, Little Rock
- Woodland Research Northwest, Rogers
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 2, 2026 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Sanro Clinical Research Group /ID# 279462, Bryant
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 14, 2026 · NCT06696755A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Pillar Clinical Research - Bentonville, Bentonville
- Pillar Clinical Research- Little Rock, Little Rock
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07140913From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.